The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-methoxybenzenesulfonamide
ID: ALA4791789
PubChem CID: 162672256
Max Phase: Preclinical
Molecular Formula: C14H13F3N2O3S
Molecular Weight: 346.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(S(=O)(=O)Nc2ccc(N)c(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C14H13F3N2O3S/c1-22-10-3-5-11(6-4-10)23(20,21)19-9-2-7-13(18)12(8-9)14(15,16)17/h2-8,19H,18H2,1H3
Standard InChI Key: GROYHDRHYSCXBH-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
24.6850 -22.0064 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2805 -21.3006 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.8715 -22.0038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6988 -21.3006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6977 -22.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4057 -22.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1154 -22.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1126 -21.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4039 -20.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9910 -20.8922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5756 -20.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5791 -20.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8721 -19.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1635 -20.0752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1663 -20.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8739 -21.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8237 -22.5271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4055 -23.3463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6977 -23.7547 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.1131 -23.7551 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.3978 -24.1608 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.4551 -19.6677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7481 -20.0774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.33 | Molecular Weight (Monoisotopic): 346.0599 | AlogP: 3.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.53 | CX Basic pKa: 2.31 | CX LogP: 2.35 | CX LogD: 2.32 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.83 | Np Likeness Score: -1.51 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |